Glucuronidation of macelignan by human liver microsomes and expressed UGT enzymes: identification of UGT1A1 and 2B7 as the main contributing enzymes

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Biopharmaceutics & drug disposition

• Publication date

  2014-12-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1002/bdd.1914PMID 25099990
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Metabolite elucidation of the Hsp90 inhibitor SNX-2112 using ultraperformance liquid chromatography/quadrupole time-of-flight mass spectrometry (UPLC-QTOF/MS)

  2014cited by this paper
• Identification of glucuronidation and biliary excretion as the main mechanisms for gossypol clearance: in vivo and in vitro evidence

  2014cited by this paper
• Quantitative prediction of glucuronidation in humans using the in vitro- in vivo extrapolation approach.

  2013cited by this paper
• Macelignan attenuated allergic lung inflammation and airway hyper-responsiveness in murine experimental asthma.

  2013cited by this paper
• Multiple biological properties of macelignan and its pharmacological implications

  2013cited by this paper
• Regioselective Glucuronidation of Flavonols by Six Human UGT1A Isoforms

  2011cited by this paper
• Substrate inhibition kinetics in drug metabolism reactions

  2011cited by this paper
• Evaluation of 3,3',4'-trihydroxyflavone and 3,6,4'-trihydroxyflavone (4'-O-glucuronidation) as the in vitro functional markers for hepatic UGT1A1.

  2011influential reference
• First-pass metabolism via UDP-glucuronosyltransferase: a barrier to oral bioavailability of phenolics.

  2011cited by this paper
• Contribution of the Different UDP-Glucuronosyltransferase (UGT) Isoforms to Buprenorphine and Norbuprenorphine Metabolism and Relationship with the Main UGT Polymorphisms in a Bank of Human Liver Microsomes

  2010cited by this paper
• Glucuronidation of Dihydrotestosterone and trans-Androsterone by Recombinant UDP-Glucuronosyltransferase (UGT) 1A4: Evidence for Multiple UGT1A4 Aglycone Binding Sites

  2010cited by this paper
• Use of Isoform-Specific UGT Metabolism to Determine and Describe Rates and Profiles of Glucuronidation of Wogonin and Oroxylin A by Human Liver and Intestinal Microsomes

  2010cited by this paper
• Effect of maceligan on the systemic exposure of paclitaxel: in vitro and in vivo evaluation.

  2010cited by this paper
• Macelignan: A New Modulator of P-Glycoprotein in Multidrug-Resistant Cancer Cells

  2009cited by this paper
• Determination of mRNA Expression of Human UDP-Glucuronosyltransferases and Application for Localization in Various Human Tissues by Real-Time Reverse Transcriptase-Polymerase Chain Reaction

  2009cited by this paper
• Macelignan attenuates activations of mitogen-activated protein kinases and nuclear factor kappa B induced by lipopolysaccharide in microglial cells.

  2009cited by this paper
• Expression of UGT1A and UGT2B mRNA in Human Normal Tissues and Various Cell Lines

  2008cited by this paper
• Protective Effects of macelignan on cisplatin-induced hepatotoxicity is associated with JNK activation.

  2008cited by this paper
• Macelignan attenuates LPS-induced inflammation and reduces LPS-induced spatial learning impairments in rats.

  2008cited by this paper
• Pharmacogenetics of Uridine Diphosphoglucuronosyltransferase (UGT) 1A Family Members and its Role in Patient Response to Irinotecan

  2006cited by this paper
• BINDING OF DRUGS TO HEPATIC MICROSOMES: COMMENT AND ASSESSMENT OF CURRENT PREDICTION METHODOLOGY WITH RECOMMENDATION FOR IMPROVEMENT

  2006cited by this paper
• Anticariogenic activity of macelignan isolated from Myristica fragrans (nutmeg) against Streptococcus mutans.

  2006cited by this paper
• Anti-oxidant and anti-inflammatory activities of macelignan in murine hippocampal cell line and primary culture of rat microglial cells.

  2005cited by this paper
• Nomenclature update for the mammalian UDP glycosyltransferase (UGT) gene superfamily.

  2005cited by this paper
• Glucuronidation and the UDP-glucuronosyltransferases in health and disease.

  2004cited by this paper
• Separation of Leucas aspera, a medicinal plant of Bangladesh, guided by prostaglandin inhibitory and antioxidant activities.

  2003cited by this paper
• Characterization of raloxifene glucuronidation in vitro: contribution of intestinal metabolism to presystemic clearance.

  2002cited by this paper
• Atypical kinetic profiles in drug metabolism reactions.

  2002cited by this paper
• Roles of glucuronidation and UDP-glucuronosyltransferases in xenobiotic bioactivation reactions.

  2000cited by this paper
• Genetic polymorphism of UDP-glucuronosyltransferase 2B7 (UGT2B7) at amino acid 268: ethnic diversity of alleles and potential clinical significance.

  2000cited by this paper
• The structure of macelignan from Myristica fragrans

  1987cited by this paper

• Antidepressant effects of ershiwei roudoukou pills and its active ingredient Macelignan: Multiple mechanisms involving oxidative stress, neuroinflammation and synaptic plasticity

  2025cites this paper
• Prediction of SPT-07A Pharmacokinetics in Rats, Dogs, and Humans Using a Physiologically-Based Pharmacokinetic Model and In Vitro Data

  2024cites this paper
• Analyzing the metabolic fate of oral administration drugs: A review and state-of-the-art roadmap

  2022cites this paper
• Industrial approach to determine the relative contribution of seven major UGT isoforms to hepatic glucuronidation.

  2020cites this paper
• Glucuronidation of icaritin by human liver microsomes, human intestine microsomes and expressed UDP-glucuronosyltransferase enzymes: identification of UGT1A3, 1A9 and 2B7 as the main contributing enzymes

  2018cites this paper
• Identification of UDP-glucuronosyltransferases 1A1, 1A3 and 2B15 as the main contributors to glucuronidation of bakuchiol, a natural biologically active compound

  2017cites this paper
• Decreased Expression of Multidrug Resistance-Associated Protein 4 (MRP4/ABCC4) Leads to Reduced Glucuronidation of Flavonoids in UGT1A1-Overexpressing HeLa Cells: The Role of Futile Recycling.

  2015cites this paper
• Accurate identification of UDP-glucuronosyltransferase 1A1 (UGT1A1) inhibitors using UGT1A1-overexpressing HeLa cells

  2015cites this paper
• Regio- and isoform-specific glucuronidation of psoralidin: evaluation of 3-o-glucuronidation as a functional marker for UGT1A9.

  2015cites this paper
• Stable knock-down of efflux transporters leads to reduced glucuronidation in UGT1A1-overexpressing HeLa cells: the evidence for glucuronidation-transport interplay.

  2015cites this paper